相关实验视频

Updated: Jun 9, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

在前列腺癌中CNIH2的表达和作用

Wei Zhang¹, Zhenhua Li¹, Yunmeng Zhang¹

¹Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030000, China.

Scientific reports

|October 21, 2024

概括

角菜家族AMPA受体辅助蛋白2 (CNIH2) 基因的低表达表明前列腺癌患者的生存率更好. 该基因作为一个独立的预后因素,为治疗和评估提供了新的途径.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

前列腺癌是全球男性的主要健康问题.
现有的评估方法有局限性,需要新的预后因素.
确定新的治疗点对于改善患者的治疗结果至关重要.

研究的目的:

为了研究菜家族AMPA受体辅助蛋白2 (CNIH2) 基因作为前列腺癌的预后因素.
探索CNIH2在前列腺癌进展中的功能作用.
评估CNIH2在个性化治疗和预后评估方面的潜力.

主要方法:

与患者生存数据相关的CNIH2基因表达的分析.
接收器运行特征 (ROC) 曲线分析以评估预后能力.
多变量分析以确定独立的预后意义.
在体外实验 (基因淘汰) 和体内研究 (裸体小鼠的瘤生长) 用于功能验证.

主要成果:

低CNIH2基因表达与前列腺癌中无进展生存率的改善相关.
CNIH2基因在1,3年和5年 (AUC) 显示出高预后准确度.
通过多变量分析,CNIH2被确定为一个独立的预后因素.
在体内抑制CNIH2抑制的前列腺癌细胞增殖,迁移,入侵和瘤生长.

结论:

CNIH2基因在前列腺癌的进展中起着重要作用.
CNIH2作为前列腺癌的新型和独立的预后生物标志物.
准CNIH2为前列腺癌治疗和预后提供了潜在的新策略.

关键词:

在CNIH2中,这是入侵的入侵.移民移民移民预测预后预测预测前列腺癌是什么意思前列腺癌是什么意思

更多相关视频

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...